GAGANDEEP BRAR MD NPI 1528323177

NPI Information

  • NPI: 1528323177
  • Provider Name: GAGANDEEP BRAR, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 15031 RINALDI ST STE 150
    MISSION HILLS, CA
    ZIP 91345
  • Phone: (818) 660-4700

Map and Directions

Get Directions

NPI Details

Gagandeep Brar, MD is a hematology and oncology internal medicine in Mission Hills, CA with 14 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Gagandeep Brar, MD NPI is 1528323177. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

15031 RINALDI ST STE 150
MISSION HILLS, CA
ZIP 91345-207
Phone: (818) 660-4700
Fax: (818) 837-1987

The NPI 1528323177 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Unclassified drugs (HCPCS:J3490)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)

The enumeration date for this NPI number is 7/10/2012 and was last updated on 6/8/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyA132193CALIFORNIAYes
2207RH0003XInternal MedicineHematology & Oncology300290NEW YORKNo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.